CRISPR Therapeutics AGCRSPNASDAQ
Loading
Operating income as a percentage of revenue
Latest
-16191.40%
↑ 29% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-22778.26%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -16191.40% | -1114.6% |
| 2024 | -1333.05% | -2116.4% |
| 2023 | -60.15% | +100.0% |
| 2022 | -154394.72% | -377514.5% |
| 2021 | 40.91% | +100.1% |
| 2020 | -49295.55% | -305523.6% |
| 2019 | 16.14% | +100.3% |
| 2018 | -5087.80% | -3126.5% |
| 2017 | -157.69% | +88.0% |
| 2016 | -1319.33% | - |